Constantin Rieger

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Reducing paralytic ileus after radical cystectomy: The role of advanced haemodynamic monitoring.

Reducing paralytic ileus after radical cystectomy: The role of advanced haemodynamic monitoring.

Journal: BJUI compass

Published: March 09, 2026

NECTIN4 Amplification Is a Frequent Event in Central Nervous System Metastases of Urothelial Carcinoma.

NECTIN4 Amplification Is a Frequent Event in Central Nervous System Metastases of Urothelial Carcinoma.

Journal: European urology open science

Published: February 11, 2026

How Often are druggable mutations detectable in Metastatic Castration Resistant Prostate Cancer?

How Often are druggable mutations detectable in Metastatic Castration Resistant Prostate Cancer?

Journal: Urologia internationalis

Published: January 11, 2026

Urine cytology clearly recommended in the S3 guideline on the primary diagnosis of urothelial carcinoma

Urine cytology clearly recommended in the S3 guideline on the primary diagnosis of urothelial carcinoma

Journal: Urologie (Heidelberg, Germany)

Published: November 21, 2025

Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany.

Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 13, 2025

Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma.

Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma.

Journal: World journal of urology

Published: April 17, 2025

Next generation sequencing (NGS)-based molecular panel analysis for metastatic prostate cancer: how often can we detect druggable mutations? : NGS for metastatic adenocarcinoma of the prostate

Next generation sequencing (NGS)-based molecular panel analysis for metastatic prostate cancer: how often can we detect druggable mutations? : NGS for metastatic adenocarcinoma of the prostate

Journal: Urologie (Heidelberg, Germany)

Published: November 26, 2024

Urothelial carcinoma of the upper and lower urinary tract-which risk factors make early detection worthwhile?

Urothelial carcinoma of the upper and lower urinary tract-which risk factors make early detection worthwhile?

Journal: Urologie (Heidelberg, Germany)

Published: October 22, 2024

Stage-dependent treatment of seminomas

Stage-dependent treatment of seminomas

Journal: Urologie (Heidelberg, Germany)

Published: September 02, 2024

TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy.

TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy.

Journal: World journal of urology

Published: August 14, 2024

New Bladder Preservation Strategies in Urothelial Carcinoma of the Bladder.

New Bladder Preservation Strategies in Urothelial Carcinoma of the Bladder.

Journal: Deutsches Arzteblatt international

Published: July 27, 2024

Cost-effectiveness Analysis in the New Era of Treatment Strategies in Metastatic Urothelial Carcinoma Based on Checkmate-901 and EV302/Keynote-A39.

Cost-effectiveness Analysis in the New Era of Treatment Strategies in Metastatic Urothelial Carcinoma Based on Checkmate-901 and EV302/Keynote-A39.

Journal: European urology oncology

Published: June 22, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026